ARVN
Price
$6.54
Change
-$0.36 (-5.22%)
Updated
Apr 4, 02:29 PM (EDT)
Capitalization
493.78M
32 days until earnings call
CMPX
Price
$1.47
Change
-$0.14 (-8.70%)
Updated
Apr 4, 02:32 PM (EDT)
Capitalization
221.94M
38 days until earnings call
Ad is loading...

ARVN vs CMPX

Header iconARVN vs CMPX Comparison
Open Charts ARVN vs CMPXBanner chart's image
Arvinas
Price$6.54
Change-$0.36 (-5.22%)
Volume$225
Capitalization493.78M
Compass Therapeutics
Price$1.47
Change-$0.14 (-8.70%)
Volume$235
Capitalization221.94M
ARVN vs CMPX Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. CMPX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CMPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ARVN: $6.90 vs. CMPX: $1.61)
Brand notoriety: ARVN and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 95% vs. CMPX: 117%
Market capitalization -- ARVN: $493.78M vs. CMPX: $221.94M
ARVN [@Biotechnology] is valued at $493.78M. CMPX’s [@Biotechnology] market capitalization is $221.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while CMPX’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 4 bearish.
  • CMPX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than CMPX.

Price Growth

ARVN (@Biotechnology) experienced а -14.18% price change this week, while CMPX (@Biotechnology) price change was -23.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

ARVN is expected to report earnings on May 06, 2025.

CMPX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($494M) has a higher market cap than CMPX($222M). CMPX YTD gains are higher at: 10.690 vs. ARVN (-64.006). CMPX has higher annual earnings (EBITDA): -54.87M vs. ARVN (-243.6M). ARVN has more cash in the bank: 1.04B vs. CMPX (127M). CMPX has less debt than ARVN: CMPX (6.63M) vs ARVN (9.7M). ARVN has higher revenues than CMPX: ARVN (263M) vs CMPX (850K).
ARVNCMPXARVN / CMPX
Capitalization494M222M223%
EBITDA-243.6M-54.87M444%
Gain YTD-64.00610.690-599%
P/E RatioN/AN/A-
Revenue263M850K30,941%
Total Cash1.04B127M818%
Total Debt9.7M6.63M146%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCMPX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTRRX19.45N/A
N/A
MFS Total Return R2
MBVKX19.44N/A
N/A
BlackRock Large Cap Focus Value K
NWAMX34.26N/A
N/A
Nationwide BNY Mellon Dyn US Eq Inc K
DIVHX27.01N/A
N/A
Cutler Equity Fund
FSUMX13.38N/A
N/A
Fidelity Series Sustainable U.S. Market

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-3.90%
AXON - ARVN
46%
Loosely correlated
-3.35%
VCYT - ARVN
46%
Loosely correlated
-5.51%
IDYA - ARVN
42%
Loosely correlated
-4.77%
ERAS - ARVN
40%
Loosely correlated
-3.97%
ATXS - ARVN
40%
Loosely correlated
-6.70%
More

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-5.03%
VCYT - CMPX
37%
Loosely correlated
-5.51%
ABOS - CMPX
34%
Loosely correlated
-8.52%
FHTX - CMPX
33%
Loosely correlated
-7.89%
ARVN - CMPX
33%
Loosely correlated
-3.90%
SANA - CMPX
33%
Poorly correlated
-15.95%
More